- Home
- Products
Rezurock (Belumosudil)
Rezurock (Belumosudil)
- Medicine Name: Rezurock
- Generic Name: Belumosudil
- Dosage Form & Strength: Tablets – 200 mg
- Manufactured By: Kadmon Holdings, Inc.
Rezurock is a selective kinase inhibitor approved for use in adult and pediatric patients (12 years and older) with chronic graft-versus-host disease (chronic GVHD) who have not responded to at least two prior systemic therapies.
Recommended Dosage:
- 200 mg orally once daily with food
- Tablets should be swallowed whole and not crushed, split, or chewed
- Take at the same time every day with a meal
- Do not take an extra dose to make up for a missed dose
Rezurock has not been extensively studied in patients with severe renal or hepatic impairment. In such cases, healthcare providers must evaluate the risk-benefit ratio before initiating treatment.
Blood Pressure Monitoring: May increase blood pressure; patients should check BP regularly and notify their doctor if elevated.
Liver Monitoring: Liver enzymes (AST, ALT) and bilirubin should be monitored at least once a month during therapy.
Pregnancy Risk: May cause fetal harm. Effective contraception is advised for both men and women of reproductive potential during treatment.
Breastfeeding: Breastfeeding is not recommended during treatment and for at least 7 days after the final dose due to unknown risks to infants.
Documents Required to Import Rezurock into India:
- Valid prescription from a licensed physician
- Diagnostic reports indicating need for treatment
- Government-issued ID proof of the patient
Availability in India:
Rezurock is a prescription-only medication and can be imported legally for personal use under the Named Patient Import Program.
Global Rare Meds Services Include:
- Sourcing authentic Rezurock from licensed suppliers in the USA, Canada, Europe, and Australia
- Transparent pricing and import assistance
- Delivery across major Indian cities including Mumbai, Delhi, Pune, Hyderabad, Kolkata, Bengaluru, Chennai, Ahmedabad, and others
Order Confirmation:
Order is confirmed after verification of a valid prescription and, if applicable, an import permit.
For queries or procurement support:
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds partners with globally accredited pharmaceutical suppliers to ensure the safe sourcing of Rezurock (Belumosudil). All shipments are processed and dispatched from our certified fulfillment center in Ambernath, Thane District, adhering to legal import standards.
We ensure:
- Regulatory compliance
- Safe packaging and delivery
- Pharmacist-verified dispensing of medication
Q: What is the generic name of Rezurock®?
A: Belumosudil
Q: Who manufactures Rezurock®?
A: Kadmon Holdings, Inc.
Q: Is Rezurock® approved by the FDA?
A: Yes, Rezurock was approved by the U.S. FDA on July 16, 2021.
Q: What is the form and strength of Rezurock®?
A: Supplied as 200 mg tablets for oral administration.
Q: What are common side effects of Rezurock®?
A: Common side effects include infections, fatigue, nausea, diarrhea, high blood pressure, cough, swelling, abdominal pain, bleeding, and musculoskeletal pain.
Q: What are the storage conditions for Rezurock®?
A: Store at 20°C to 25°C (68°F to 77°F). Store in original container to protect from moisture and do not repackage.
Q: How much does Rezurock® cost in India?
A: Pricing may vary. Contact info@globalraremeds.com or call/WhatsApp +91-99675 15602 for accurate pricing and delivery timelines.
Q: Is it legal to purchase Rezurock® online in India?
A: Yes, Global Rare Meds can facilitate legal procurement through a valid prescription and compliance with Indian import regulations.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
